L.A. Now
Flooding, thunder and lightning are reported amid triple-digit heat

Topics

Merck & Company Incorporated
Melanoma drug described as breakthrough gets FDA nod
Melanoma drug described as breakthrough gets FDA nod

The Food and Drug Administration on Thursday gave its speedy approval to a treatment for melanoma that was found to shrink tumors by more than 30% in more than a third of patients with advanced cases of the deadly skin cancer. The FDA designated the immunotherapy drug pembrolizumab -- to be marketed as Keytruda -- a "breakthrough therapy" after early clinical trials suggested it might offer "substantial improvement over available therapies" for melanoma. That status allowed an accelerated evaluation of Keytruda. And it allows the drug's maker, Merck, to offer the drug to patients whose melanoma is no longer responding to other treatments, even as it continues to...

Loading